These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 1320925)

  • 41. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
    Ritchie MH; Oakes JE; Lausch RN
    Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of herpes virus entry mediator (HVEM) in the cornea and trigeminal ganglia of normal and HSV-1 infected mice.
    Kovacs SK; Tiwari V; Prandovszky E; Dosa S; Bacsa S; Valyi-Nagy K; Shukla D; Valyi-Nagy T
    Curr Eye Res; 2009 Oct; 34(10):896-904. PubMed ID: 19895317
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of bilateral retinal necrosis in mice by unilateral intracameral inoculation of a glycoprotein-C deficient clinical isolate of herpes simplex virus type 1.
    Liu Y; Sakai Y; Minagawa H; Toh Y; Ishibashi T; Inomata H; Mori R
    Arch Virol; 1993; 129(1-4):105-18. PubMed ID: 8385909
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protection against herpetic ocular disease by immunotherapy with monoclonal antibodies to herpes simplex virus glycoproteins.
    Metcalf JF; Chatterjee S; Koga J; Whitley RJ
    Intervirology; 1988; 29(1):39-49. PubMed ID: 2838428
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Herpes simplex virus DNA in corneal transplants: prospective study of 38 recipients.
    Robert PY; Adenis JP; Denis F; Alain S; Ranger-Rogez S
    J Med Virol; 2003 Sep; 71(1):69-74. PubMed ID: 12858411
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of herpes simplex virus type 1 in herpetic ocular diseases by DNA-DNA hybridization using a biotinylated DNA probe.
    Nago R; Hayashi K; Ochiai H; Kubota Y; Niwayama S
    J Med Virol; 1988 Jul; 25(3):259-70. PubMed ID: 2844977
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Herpes simplex virus type 1 transcription is not detectable in quiescent human stromal keratitis by in situ hybridization.
    Laycock KA; Lee SF; Stulting RD; Croen KD; Ostrove JM; Straus SE; Pepose JS
    Invest Ophthalmol Vis Sci; 1993 Feb; 34(2):285-92. PubMed ID: 8382667
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Latency of herpes simplex virus in ocular tissue of mice.
    Openshaw H
    Infect Immun; 1983 Feb; 39(2):960-2. PubMed ID: 6299954
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recovery of herpes simplex virus from ocular tissues of latently infected inbred mice.
    Abghari SZ; Stulting RD
    Invest Ophthalmol Vis Sci; 1988 Feb; 29(2):239-43. PubMed ID: 2828265
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reactivation of latent infection and induction of recurrent herpetic eye disease in mice.
    Shimeld C; Hill TJ; Blyth WA; Easty DL
    J Gen Virol; 1990 Feb; 71 ( Pt 2)():397-404. PubMed ID: 2155293
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapeutic efficacy of DNA encoding IFN-alpha1 against corneal HSV-1 infection.
    Noisakran SJ; Carr DJ
    Curr Eye Res; 2000 May; 20(5):405-12. PubMed ID: 10855035
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reliability of the herpes simplex virus immunofluorescent test in corneal disease.
    Bordin P; Merlin U; Pugina P; Benzi G; Sichirollo R
    Eur J Ophthalmol; 1992; 2(4):175-8. PubMed ID: 1336997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Restriction of latent herpes virus infection in rabbits immunized with subviral herpes simplex virus vaccine.
    Rajcáni J; Kutinová L; Vonka V
    Acta Virol; 1980 May; 24(3):183-93. PubMed ID: 6107035
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunomodulation of experimental murine herpes simplex keratitis: II. Glycoprotein D protection.
    Foster CS; Sandstrom IK; Wells PA; Thompson P; Daigle J; Opremcak EM
    Curr Eye Res; 1988 Nov; 7(11):1051-61. PubMed ID: 2854037
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Persistence of herpes simplex virus type 1 DNA in chronic conjunctival and eyelid lesions of mice.
    Maggs DJ; Chang E; Nasisse MP; Mitchell WJ
    J Virol; 1998 Nov; 72(11):9166-72. PubMed ID: 9765463
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Application of polymerase chain reaction for quick assay of herpes simplex viral acute ocular infection and ganglionic latent infection].
    Fan J; Zhang WH; Wu YY
    Zhonghua Yan Ke Za Zhi; 1994 Jul; 30(4):298-300. PubMed ID: 7843025
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Previous immunization of mice with herpes simplex virus type-1 strain MP protects against secondary corneal infection.
    Sandstrom IK; Foster CS; Wells PA; Knipe D; Caron L; Greene MI
    Clin Immunol Immunopathol; 1986 Aug; 40(2):326-34. PubMed ID: 3013476
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of acyclovir on thermal stress-induced herpesvirus reactivation.
    Gebhardt BM; Kaufman HE; Hill JM
    Curr Eye Res; 2004; 29(2-3):137-44. PubMed ID: 15512960
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Corneal Langerhans cell dynamics after herpes simplex virus reactivation.
    Miller JK; Laycock KA; Nash MM; Pepose JS
    Invest Ophthalmol Vis Sci; 1993 Jun; 34(7):2282-90. PubMed ID: 8389344
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Herpes simplex virus latency, reactivation, and a new antiviral therapy for herpetic keratitis].
    Shimomura Y
    Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):247-64; discussion 265. PubMed ID: 18411713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.